Benign Prostatic Hyperplasia (BPH) in Geriatric Patients (2022)-BPH Fact Sheet 2022

BPH Fact Sheet 2022

Pdf Summary

Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland that occurs in the male genitourinary system. It is a common cause of lower urinary tract symptoms (LUTS) in men, as the prostate grows and puts pressure on the urethra and urinary bladder. Hormonal changes, aging, and genetics are believed to be risk factors for BPH. Diagnosis of BPH involves a medical history, symptom index, physical exam, and laboratory tests such as urinalysis and prostate-specific antigen (PSA) blood testing.<br /><br />Management of BPH aims to minimize symptoms and prevent disease progression. Conservative management includes lifestyle changes such as weight loss, fluid intake reduction, and avoidance of bladder irritants. Medication options for BPH include alpha blockers, 5-alpha reductase inhibitors, and phosphodiesterase-5 inhibitors. Combination therapy with alpha blockers and 5-alpha reductase inhibitors is recommended for men with enlarged prostates. Other options include anticholinergic agents, herbal remedies, and interventional procedures like transurethral resection of the prostate (TURP), laser surgery, and minimally invasive surgical techniques.<br /><br />When coding BPH procedures, healthcare providers can use Category I CPT codes provided by the American Medical Association, such as 52601, 52648, 52649, and 53850. ICD-10 codes maintained by the World Health Organization, such as N40.0, N40.1, N40.2, and N40.3, are commonly used for BPH diagnoses. HCPCS codes developed by the Centers for Medicare & Medicaid can also be used to bill medical procedures related to BPH.<br /><br />Summary Not Available

Keywords

Benign Prostatic Hyperplasia

BPH

prostate gland enlargement

lower urinary tract symptoms

LUTS

diagnosis of BPH

management of BPH

medication options for BPH

interventional procedures for BPH

BPH coding and billing